Anti-TREML4 antibodies are used in the immunodetection of the protein triggering receptor expressed on myeloid cells like 4. In humans, the canonical protein has a reported length of 200 amino acid residues and a mass of 21.9 kDa. It has been described to be a secreted protein. TREML4 is known to be involved with innate immune responses. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include TREM like transcript 4, triggering receptor expressed on myeloid cells-like protein 4, and trem-like transcript 4 protein. A number of TREML4 antibodies have been mentioned in research publications and have associated citations. Flow Cytometry is a widely used application for these antibodies. In addition, Western Blot is also a common application.